20 published test results across 7 vendors · latest: 17 Sept 2026
| # | Vendor | Tests | Price/mg | Score |
|---|---|---|---|---|
| 1 | RRetalux Unverified | 4 | $0.86 | 78 |
| 2 | LLiliPeptide Unverified | 3 | $1.15 | 76 |
| 3 | RReta-Peptide | 4 | $0.66 | 72 |
| 4 | DDankang BioHealth Unverified | 3 | $0.75 | 63 |
| 5 | HHeman Peptide HM Unverified | 3 | $1.05 | 62 |
| 10 | BBlessed Peptides Unverified | 1 | — | — |
Computed from publicly published third-party results. How scoring works · every listing is free and un-buyable. Vendors marked Unverified appear for their published results but are left out of the vendor rankings.
SS-31 is the research-market name for elamipretide, a mitochondria-targeted peptide with real clinical trials behind it in mitochondrial disease. Molecule same, manufacturing standards not. Under its drug name, elamipretide, it has been tested in trials for primary mitochondrial myopathy and Barth syndrome.
Dosing volumes are arithmetic; the peptide calculator handles them. Whether the vial matches its label is a testing question.
The published record here covers 7 vendors and 20 recorded tests, which is what the rankings above are built from.
Nothing on this page is medical advice; compounds shown are sold for research purposes only. Data is aggregated from publicly published third-party results and traces to its source.